株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ポイントオブケア分子診断(mPOC)装置の世界市場:2020年~2024年

Global Molecular Point of Care (mPOC) Devices Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 934838
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.72円で換算しております。
ポイントオブケア分子診断(mPOC)装置の世界市場:2020年~2024年 Global Molecular Point of Care (mPOC) Devices Market 2020-2024
出版日: 2020年04月28日 ページ情報: 英文 120 Pages
概要

世界のポイントオブケア分子診断(mPOC)装置市場は、2020年から2024年の予測期間中に15%のCAGRで成長し、8億1,662万米ドルの規模に達する見込みです。当市場は、感染症の有病率の増加とM&A活動の増加などが主な成長要因となっています。

当レポートでは、世界のポイントオブケア分子診断(mPOC)装置市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019-2024年の予測

ファイブフォース分析

用途別市場セグメンテーション

  • 市場セグメンテーション
  • 用途別比較:市場規模・予測(2019年~2024年)
  • 感染症
  • 腫瘍学
  • その他
  • アプリケーション別の市場機会

顧客情勢

  • 概要

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模・予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 地域別市場機会
  • 数量的成長要因 - 需要主導型成長
  • 数量的成長要因 - 供給主導型成長
  • 数量的成長要因 - 外部要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • 概要
  • 情勢の革新

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Credo Biomedical Pte. Ltd.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.

付録

目次
Product Code: IRTNTR43290

Technavio has been monitoring the molecular point of care (mPOC) devices market and it is poised to grow by $ 816.62 million during 2020-2024 progressing at a CAGR of 15% during the forecast period. Our reports on molecular point of care (mPOC) devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic and infectious diseases and the increasing number of M&A activities.

The molecular point of care (mPOC) devices market analysis includes application segment and geographic landscapes

Technavio's ‘ molecular point of care (mPOC) devices market is segmented as below

By Application

  • Infectious diseases
  • oncology
  • others

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising number of product launches as one of the prime reasons driving the molecular point of care (mPOC) devices market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our molecular point of care (mPOC) devices market covers the following areas:

  • Molecular point of care (mPOC) devices market sizing
  • Molecular point of care (mPOC) devices market forecast
  • Molecular point of care (mPOC) devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular point of care (mPOC) devices market vendors that include Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd. Also, the molecular point of care (mPOC) devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019-2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Infectious diseases - Market size and forecast 2019-2024
  • Oncology - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Credo Biomedical Pte. Ltd.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Infectious diseases - Market size and forecast 2019-2024 ($ million)
  • 24: Infectious diseases - Year-over-year growth 2019-2024 (%)
  • 25: Oncology - Market size and forecast 2019-2024 ($ million)
  • 26: Oncology - Year-over-year growth 2019-2024 (%)
  • 27: Others - Market size and forecast 2019-2024 ($ million)
  • 28: Others - Year-over-year growth 2019-2024 (%)
  • 29: Market opportunity by Application
  • 30: Customer landscape
  • 31: Market share by geography 2019-2024 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: Europe - Market size and forecast 2019-2024 ($ million)
  • 36: Europe - Year-over-year growth 2019-2024 (%)
  • 37: Asia - Market size and forecast 2019-2024 ($ million)
  • 38: Asia - Year-over-year growth 2019-2024 (%)
  • 39: ROW - Market size and forecast 2019-2024 ($ million)
  • 40: ROW - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Abbott Laboratories - Overview
  • 50: Abbott Laboratories - Business segments
  • 51: Abbott Laboratories - Key offerings
  • 52: Abbott Laboratories - Key customers
  • 53: Abbott Laboratories - Segment focus
  • 54: bioMerieux SA - Overview
  • 55: bioMerieux SA - Business segments
  • 56: bioMerieux SA - Key offerings
  • 57: bioMerieux SA - Key customers
  • 58: bioMerieux SA - Segment focus
  • 59: Bio-Rad Laboratories Inc. - Overview
  • 60: Bio-Rad Laboratories Inc. - Business segments
  • 61: Bio-Rad Laboratories Inc. - Key offerings
  • 62: Bio-Rad Laboratories Inc. - Key customers
  • 63: Bio-Rad Laboratories Inc. - Segment focus
  • 64: Credo Biomedical Pte. Ltd. - Overview
  • 65: Credo Biomedical Pte. Ltd. - Product and service
  • 66: Credo Biomedical Pte. Ltd. - Key offerings
  • 67: Credo Biomedical Pte. Ltd. - Key customers
  • 68: Credo Biomedical Pte. Ltd. - Segment focus
  • 69: Danaher Corp. - Overview
  • 70: Danaher Corp. - Business segments
  • 71: Danaher Corp. - Key offerings
  • 72: Danaher Corp. - Key customers
  • 73: Danaher Corp. - Segment focus
  • 74: F. Hoffmann-La Roche Ltd. - Overview
  • 75: F. Hoffmann-La Roche Ltd. - Business segments
  • 76: F. Hoffmann-La Roche Ltd. - Key offerings
  • 77: F. Hoffmann-La Roche Ltd. - Key customers
  • 78: F. Hoffmann-La Roche Ltd. - Segment focus
  • 79: Meridian Bioscience Inc. - Overview
  • 80: Meridian Bioscience Inc. - Business segments
  • 81: Meridian Bioscience Inc. - Key offerings
  • 82: Meridian Bioscience Inc. - Key customers
  • 83: Meridian Bioscience Inc. - Segment focus
  • 84: Oxford Nanopore Technologies Ltd. - Overview
  • 85: Oxford Nanopore Technologies Ltd. - Product and service
  • 86: Oxford Nanopore Technologies Ltd. - Key offerings
  • 87: Oxford Nanopore Technologies Ltd. - Key customers
  • 88: Oxford Nanopore Technologies Ltd. - Segment focus
  • 89: QIAGEN N.V. - Overview
  • 90: QIAGEN N.V. - Business segments
  • 91: QIAGEN N.V. - Key offerings
  • 92: QIAGEN N.V. - Key customers
  • 93: QIAGEN N.V. - Segment focus
  • 94: QuantuMDx Group Ltd. - Overview
  • 95: QuantuMDx Group Ltd. - Product and service
  • 96: QuantuMDx Group Ltd. - Key offerings
  • 97: QuantuMDx Group Ltd. - Key customers
  • 98: QuantuMDx Group Ltd. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations